| Valuation method | Value, € | Upside, % |
|---|---|---|
| Artificial intelligence (AI) | n/a | n/a |
| Intrinsic value (DCF) | n/a | |
| Graham-Dodd Method | 0.30 | -94 |
| Graham Formula | 0.03 | -99 |
Scientific Brain Training SA (MLSBT.PA) is a France-based company specializing in cognitive training and human resources consultancy. Founded in 2000 and headquartered in Lyon, the company offers innovative solutions for behavioral competency assessment, cognitive health, and neurorehabilitation. Its services cater to individuals, healthcare professionals, and organizations, focusing on improving cognitive functions across all age groups—from children to seniors. Operating in the healthcare sector, Scientific Brain Training SA provides software and training programs designed to address cognitive disorders, including neurodegenerative and neuropsychiatric conditions. The company's dual focus on HR consultancy and smart health services positions it uniquely in the medical care facilities industry. With a strong emphasis on neuroscience-backed methodologies, Scientific Brain Training SA aims to enhance cognitive performance and workplace productivity while supporting clinical treatment and prevention strategies.
Scientific Brain Training SA presents a niche investment opportunity in the cognitive health and HR consultancy space. The company reported revenue of €12.9 million in FY 2020 but posted a net loss of €608,189, reflecting operational challenges. Its low beta (0.056) suggests minimal correlation with broader market movements, making it a potentially low-volatility holding. However, the lack of profitability and a dividend yield of 0% may deter income-focused investors. Positive operating cash flow (€1.36 million) indicates some financial stability, but high capital expenditures relative to earnings could pressure liquidity. Investors should weigh the company's specialized market positioning against its financial performance and growth prospects in the evolving cognitive health industry.
Scientific Brain Training SA operates in a specialized segment combining cognitive health solutions and HR consultancy, differentiating itself from traditional medical care providers. Its competitive advantage lies in its neuroscience-based approach, offering validated cognitive training tools for both clinical and corporate applications. The company's software solutions for neurodegenerative and neuropsychiatric disorders provide a technological edge, particularly in the European market. However, its small scale (€12.9M revenue) limits its ability to compete with larger healthcare IT firms in terms of R&D budgets and global reach. The HR consultancy segment faces competition from established players in workforce assessment and training. Scientific Brain Training's dual focus could be a strength if synergies are realized, but it also risks spreading resources thin. The company's French base offers regional market familiarity but may hinder expansion into non-European markets where local competitors dominate. Its intellectual property in cognitive training methodologies is a key asset, though scalability remains a challenge.